Education
About Us
Working with TipRanks
Follow Us
180 Life Sciences (ATNF)
NASDAQ:ATNF
Total Valuation
180 Life Sciences has a market cap or net worth of $514.47M. The enterprise value is ―.
Market Cap$514.47M
Enterprise Value―
Share Statistics
180 Life Sciences has 154,032,090 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding154,032,090
Owned by Insiders60.06%
Owned by Institutions<0.01%
Financial Efficiency
180 Life Sciences’s return on equity (ROE) is -0.67 and return on invested capital (ROIC) is -64.16%.
Return on Equity (ROE)-0.67
Return on Assets (ROA)-0.48
Return on Invested Capital (ROIC)-64.16%
Return on Capital Employed (ROCE)-0.68
Revenue Per Employee0.00
Profits Per Employee-1.54M
Employee Count4
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of 180 Life Sciences is ―. 180 Life Sciences’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.18
Price to FCF0.00
Price to Operating Cash Flow-18.50
PEG Ratio―
Income Statement
In the last 12 months, 180 Life Sciences had revenue of 0.00 and earned -6.17M in profits. Earnings per share was -15.49.
Revenue0.00
Gross Profit-58.28K
Operating Income-6.32M
Pretax Income-6.46M
Net Income-6.17M
EBITDA-6.32M
Earnings Per Share (EPS)-15.49
Cash Flow
In the last 12 months, operating cash flow was -3.16M and capital expenditures 0.00, giving a free cash flow of -3.16M billion.
Operating Cash Flow-3.16M
Free Cash Flow-3.16M
Free Cash Flow per Share-0.02
Dividends & Yields
180 Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.60
52-Week Price Change488.51%
50-Day Moving Average1.83
200-Day Moving Average1.69
Relative Strength Index (RSI)88.11
Average Volume (3m)5.03M
Important Dates
180 Life Sciences upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
180 Life Sciences as a current ratio of 1.47, with Debt / Equity ratio of 26.25%
Current Ratio1.47
Quick Ratio1.47
Debt to Market Cap0.09
Net Debt to EBITDA0.70
Interest Coverage Ratio0.00
Taxes
In the past 12 months, 180 Life Sciences has paid -296.02K in taxes.
Income Tax-296.02K
Effective Tax Rate0.05
Enterprise Valuation
180 Life Sciences EV to EBITDA ratio is 0.44, with an EV/FCF ratio of 1.87.
EV to Sales0.00
EV to EBITDA0.44
EV to Free Cash Flow1.87
EV to Operating Cash Flow1.87
Balance Sheet
180 Life Sciences has $2.22M in cash and marketable securities with ― in debt, giving a net cash position of -$805.89K billion.
Cash & Marketable Securities$2.22M
Total Debt―
Net Cash-$805.89K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share$1.78
Margins
Gross margin is 35.44%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin35.44%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for 180 Life Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―